LakeShore Accounts Payable from 2010 to 2025

LSBPW Stock   0.07  0  2.04%   
LakeShore Biopharma Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 53.7 M in 2025. Accounts Payable is the amount LakeShore Biopharma Co, owes to suppliers or vendors for products or services received but not yet paid for. It represents LakeShore Biopharma's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
77.9 M
Current Value
53.7 M
Quarterly Volatility
24.3 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check LakeShore Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LakeShore Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.9 M, Interest Expense of 29.6 M or Selling General Administrative of 130.7 M, as well as many indicators such as Price To Sales Ratio of 1.07, Dividend Yield of 0.0 or PTB Ratio of 1.05. LakeShore financial statements analysis is a perfect complement when working with LakeShore Biopharma Valuation or Volatility modules.
  
Check out the analysis of LakeShore Biopharma Correlation against competitors.

Latest LakeShore Biopharma's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of LakeShore Biopharma Co, over the last few years. An accounting item on the balance sheet that represents LakeShore Biopharma obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of LakeShore Biopharma Co, are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. LakeShore Biopharma's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LakeShore Biopharma's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

LakeShore Accounts Payable Regression Statistics

Arithmetic Mean30,682,461
Geometric Mean24,426,162
Coefficient Of Variation79.24
Mean Deviation19,661,434
Median16,383,236
Standard Deviation24,311,405
Sample Variance591T
Range64.1M
R-Value0.75
Mean Square Error277.3T
R-Squared0.56
Significance0.0008
Slope3,828,488
Total Sum of Squares8865.7T

LakeShore Accounts Payable History

202553.7 M
202477.9 M
202367.8 M
202280.4 M
202130.8 M

About LakeShore Biopharma Financial Statements

LakeShore Biopharma investors use historical fundamental indicators, such as LakeShore Biopharma's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LakeShore Biopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable77.9 M53.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LakeShore Stock Analysis

When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.